Access to diagnostic evaluation and treatment for dementia in Europe

International Journal of Geriatric Psychiatry

Volumn 22, Issue 1, 2007, Pages 47-54

  Waldemar, Gunhild ^a   Phung, Kieu T T ^a   Burns, Alistair ^b   Georges, Jean ^c   Hansen, Finn Ronholt ^d   Iliffe, Steven ^e   Marking, Christine ^f   Rikkert, Marcel Olde ^g   Selmes, Jacques ^f   Stoppe, Gabriela ^h   Sartorius, Norman ⁱ  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ALZHEIMER EUROPE   (Luxembourg)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^f Marking Public Affairs sprl ^*  (Spain)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY OF BASEL   (Switzerland)

ⁱ International Association for the Improvement of Mental Health Programmes   (Switzerland)

Author keywords

Alzheimer's disease; Dementia; Diagnosis; Diagnostic assessment; Diagnostic evaluation; Early diagnosis; Early treatment; Pharmacological treatment

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; MEMANTINE; RIVASTIGMINE;

ALZHEIMER DISEASE; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; CULTURAL FACTOR; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY INTERVENTION; EUROPE; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HOSPITALIZATION; HUMAN; MEDICAL SPECIALIST; PATIENT COMPLIANCE; PREVALENCE; PRIMARY HEALTH CARE; RESOURCE ALLOCATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; WELLBEING;

DELIVERY OF HEALTH CARE, INTEGRATED; DEMENTIA; EARLY DIAGNOSIS; EUROPE; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES FOR THE AGED; HUMANS; PATIENT CARE TEAM; PRACTICE GUIDELINES; PRIMARY HEALTH CARE;

EID: 33846328694     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1652     Document Type: Review

References (61)

1. Acton GJ, Kang J. 2001. Interventions to reduce the burden of caregiving for an adult with dementia: a meta-analysis. Res Nurs Health 24(5): 349-360.
2. Armstrong RA, Lantos PL, Cairns NJ. 2005. Overlap between neurodegenerative disorders. Neuropathalogy 25(2): 111-124.
3. Belmin J. 2003. Contribution of interventional studies of family caregivers of patients with Alzheimer's disease. Presse Med 32 (24 Suppl): S9-13.
4. Birks J. 2006. Cholinesterase inhihitors for Alzheimer's disease. The Cochrane Database of Systemic Reviews. http:// www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD00593/ frame.html. Access date: 2/8/2006.DOI:10.1002/14651858.CD005593.
5. Birks J, Evans JG, Iakovidou V, Tsolaki M. 2000. Rivastigmine for Alzheimer's disease. The Cochrane Database of Systemic Reviews. http:// www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001191/ frame.html. Access date: 2/8/2006. DOI:10.1002/14651858.CD001191.
6. Birks J, Harvey RJ. 2006. Donepezil for dementia due to Alzheimer's disease. The Cochrane Database of Systemic Reviews. http:// www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005593/ frame.html. Access date: 2/6/2006. DOI:10.1002/14651858.CD001190.pub2.
7. Boomsma LJ, Boukes FS, Wind AW, Assendelft WJ, Nederlands Huisartsen Genootschap. 2004. Summery of the practice guideline 'Dementia' (second revision) from the Dutch College of General Practitioners. Ned Tijdschr Geneeskd 148(24): 1191-1197. (Article in Dutch).
8. Boustani M, Peterson B, Hanson L, et al. 2003. Screening for dementia in primary care: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 138(11): 927-937.
9. Bridges-Webb C, Wolk J, Pond D, Britt H. 2003. Care of Patients with Dementia in General Practice. Royal Australian College of General Practitioners. www.racgp.org.au/downloads/pdf/ GP_dementia_guidelines.pdf. Access date: 12/15/2004.
10. Bryans M, Keady J, Turner S, et al. 2003. An exploratory survey into primary care nurses and dementia care. Br J Nurs 12(17): 1029-1037.
11. Corrada M, Brookmeyer R, Kawas C. 1995. Sources of variability in prevalence rates of Alzheimer's disease. Int J Epidemiol 24(5): 1000-1005.
12. Cummings JL, Frank JC, Cherry D, et al. 2002a. Guidelines for managing Alzheimer's disease: part I. Assessment. Am Fam Physician 65(11): 2263-2272.
13. Cummings JL, Frank JC, Cherry D, et al. 2002b. Guidelines for managing Alzheimer's disease: Part II. Treatment. Am Fam Physician 65(12): 2525-2534.
14. Dartigues JF, Helmer C, Dubois B, et al. 2002. Alzheimer's disease: a public health problem: yes, but a priority?. Rev Neural (Paris) 158(3): 311-315.
15. Doody RS, Stevens JC, Beck C, et al. 2001. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56(9): 1154-1166.
16. Downs M, Turner S, Bryans M, et al. 2006. Effectiveness of educational interventions in improving detection and management of dementia in primary BMJ 331(7543): 692-696.
17. Errebo-Knudsen L, Dinesen O, Jakobsen BG, Kristensen KA. 2003. Are the Danish Society of General Practitioners' clinical guidelines concerning 'Identification and investigation of dementia and dementia-like conditions' useful as the basis of dementia investigation in general practice? Ugeskr Laeger 165(20): 2105-2107. (article in Danish).
18. Greiner LH, Snowdon DA. 1997. Underrecognition of dementia by caregivers cuts across cultures. JAMA 277(22): 1757-1759.
19. Hsian CL, Auchus AP, Ming CK, et al. 2001. Clinical Practice Guidelines. Dementia. Ministry of Health, Singapore. www.moh.gov.sg/cmaweb/ attachments/publication/Dementia_PDF.pdf. Access date: 1/10/2005.
20. Iliffe S, Manthorpe J. 2004. The hazards of early recognition of dementia: a risk assessment. Aging Ment Health 8(2): 99-105.
21. Jones RG, Benbow S, Bullock R, et al. 2005. Forgetful but not forgotten: assessment and aspects of treatment of people with dementia by a specialist old age psychiatry service. Royal College of Psychiatrists. Council Report CR119.London.http://www.rcpsych.ac.uk/publications/ gaskell/shopping/system/index.html. Access date: 2/8/2006.
22. Jonsson L. 2004. Economic evidence in dementia: a review. Eur J Health Econ 5 (Suppl 1): S30-S35.
23. Jorm AF, Korten AE, Henderson AS. 1987. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 76(5): 465-479.
24. Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, van den BH. 2005. Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ 331(7512): 321-327.
25. Knopman D, Donohue JA, Gutterman EM. 2000. Patterns of care in the early stages of Alzheimer's disease: impediments to timely diagnosis. J Am Geriatr Soc 48(3): 300-304.
26. Lobo A, Launer LJ, Fratiglioni L, et al. 2000. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54 (11 Suppl 5): S4-S9.
27. Loy C, Schneider L. 2006. Galantamine for Alzheimer's disease and mild cognitive impairment. The Cochrane Database of Systemic Reviews. http:// www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001747/ frame.html. Access date: 2/7/2006.DOI:10.1002/14651858.CD001747.pub3.
28. Manthorpe J, Iliffe S, Eden A, 2003a. The implications of the early recognition of dementia for multiprofessional teamworking: conflicts and contradictions in practitioner perspectives. Dementia 2(2): 163-179.
29. Manthorpe J, Iliffe S, Eden A. 2003b. Early recognition of dementia by nurses. J Adv Nurs 44(2): 183-191.
30. Mendonca Lima CA, Levav I, Jacobsson L, Rutz W. 2003. Stigma and discrimination against older people with mental disorders in Europe. Int J Geriatr Psychiatry 18(8): 679-682.
31. Muller U, Wolf H, Kiefer M, Gertz HJ. 2003. A systemic comparison of National and International Dementia Guidelines. Fortschr Neurol Psychiat 71: 285-295. (article in German).
32. Musico M, Caltagirone C, Sorbi S, et al. 2004. Italian Neurological Society guidelines for the diagnosis of dementia: Revision 1. Neurological Sciences 25(3): 154-167.
33. National Institute for Clinical Excellence. 2001. Guidance on the Use of Donepezil, Rivastigmine and Galantamine for the Treatment of Alzheimer's Disease. National Institute for Clinical Excellence. www.nice.org.uk/pdf/ ALZHEIMER_full_guidance.pdf. Access date: 1/10/2005.
34. Nestor PJ, Scheltens P, Hodges JR. 2004. Advances in the early detection of Alzheimer's disease. Nat Med 10 (Suppl): S34-S41.
35. Olafsdottir M, Foldevi M, Marcusson J. 2001. Dementia in primary care: why the low detection rate? Scand J Prim Health Care 19(3): 194-198.
36. Olesen J, Leonardi M. 2003. The burden of brain diseases in Europe. Eur J Neurol 10(5): 471-477.
37. Oude Voshaar RC, Burns A, Olde Rikkert MG. 2006. Alarming arbitrariness in EU prescription and reimbursement criteria for anti-dementia drugs. Int J Geriatr Psychiatry 21(1): 29-31.
38. Patterson C, Gauthier S, Bergman H, et al. 2001. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. Can J Neurol Sci 28 (Suppl 1): S3-S16.
39. Petersen RC, Stevens JC, Ganguli M, et al. 2001. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56(9): 1133-1142.
40. Rabins P, Blan W, Bright-Long L, et al. 2002. Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. In American Psychiatric Association. Guidelines for the Treatment of Psychiatric Disorders. American Psychiatric Press: Washington, DC; 67-135.
41. Sastre AA, Sherriff F, McShane R. 2005. Memantine for dementia. The Cochrane Database of Systemic Reviews. http:// www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003154/ frame.html. Access date: 2/8/2006.DOI:10.1002/14651858. CD003154.pub4.
42. Seltzer B, Zolnouni P, Nunez M, et al. 2004. Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial. Arch Neurol 61(12): 1852-1856.
43. Sorbi S, Alberoni M, Alfieri P, et al. 2000. Guidelines for the diagnosis of dementia and Alzheimer's disease. The Dementia Study Group of the Italian Neurological Society. Neurol Sci 21(4): 187-194.
44. Turner S, Iliffe S, Downs M, et al. 2004. General practitioners' knowledge, confidence and attitudes in the diagnosis and management of dementia. Age Ageing 33(5): 461-467.
45. Valcour VG, Masaki KH, Curb JD, Blanchette PL. 2000. The detection of dementia in the primary care setting. Arch Intern Med 160(19): 2964-2968.
46. van Hout H, Vernooij-Dassen M, Poels P, Hoefnagels W, Grol R. 2000. Are general practitioners able to accurately diagnose dementia and identify Alzheimer's disease? A comparison with an outpatient memory clinic. Br J Gen Pract 50(453): 311-312.
47. van Hout HP, Vernooij-Dassen MJ, Hoefnagels WH, et al. 2002. Dementia: predictors of diagnostic accuracy and the contribution of diagnostic recommendations. J Fam Pract 51(8): 693-699.
48. Verhey FR, Jolles J, Ponds RW, et al. 1993. Diagnosing dementia: a comparison between a monodisciplinary and a multidisciplinary approach. J Neuropsychiatry Clin Neurosci 5(1): 78-85.
49. Vernooij-Dassen M, Olde Rikkert MG. 2004. Personal disease management in dementia care. Int J Geriatr Psychiatry 19(8): 715-717.
50. Veroooij-Dassen M, Lamers C, Bor J, Felling A, Grol R. 2000. Prognostic factors of effectiveness of a support program for caregivers of dementia patients. Int J Aging Hum Dev 51(4): 259-274.
51. Vernooij-Dassen MJ, Moniz-Cook ED, Woods RT, et al. 2005. Factors affecting timely recognition and diagnosis of dementia across Europe: from awareness to stigma. Int J Geriatr Psychiatry 20(4): 377-386.
52. Vogel A, Stokholm J, Gade A, et al. 2004. Awareness of deficits in mild cognitive impairment and Alzheimer's disease: do MCI patients have impaired insight? Dement Geriatr Cogn Disord 17(3): 181-187.
53. Waldemar G, Dubois B, Emre M, et al. 2000. Diagnosis and management of Alzheimer's disease and other disorders associated with dementia. The role of neurologists in Europe. European Federation of Neurological Societies. Eur J Neurol 7(2): 133-144.
54. Waldemar G, Dubois S, Emre M, et al. 2006. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia. Eur J Neurol (in press).
55. Waldorff FB, Moller S. 2001. Diagnostic evaluation of dementia in general practice in Denmark. A national survey. Scand J Prim Health Care 19(2): 117-121.
56. Watson R. 2005. Sex inequalities in health care need tackling. BMJ 330(7495): 808.
57. WHO. 2003. Mental health in the WHO European Region. World Health Organization Europe. www.euro.who.int/documentation/mediacentre/ fs0303e.pdf. Access date: 1/20/2005.
58. WHO. 2004. Revised Global Burden of Disease Estimate for Regions: mortality, incidence, prevalence, YLL, YLD, and DALY by sex, cause and regions, estimates for 2002 as reported in the World Health Report 2004. World Health Organization. http://www3.who.int/whosis/ menu.cfm?path=whosis,bod,burden,burden€timates, burden_estimates_2002N&language=english. Access date: 11/20/2004.
59. Wilkinson D, Stave C, Keohane D, Vincenzino O. 2004. The role of general practitioners in the diagnosis and treatment of Alzheimer's disease: a multinational survey. J Int Med Res 32(2): 149-159.
60. Wimo A, Winblad B, Aguero-Torres H, von Strauss E. 2003. The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord 17(2): 63-67.
61. Woods RT, Moniz-Cook E, Iliffe S, et al. 2003. Dementia: issues in early recognition and intervention in primary care. J R Soc Med 96(7): 320-324.